Global Social Security Review

Trends in Quality Management of Assisted Reproductive Technology (ART) Medical Institutions in the United Kingdom

  • Author

    Yoon, Ji Won

  • Page

    32-47

  • PubDate

    2026. 03.

  • Language

    kor

This article examines the UK quality management system for medical institutions practicing assisted reproductive technology (ART) procedures and discusses its implications for policymaking in Korea. The survey of the system centers around the Human Fertilisation and Embryology Authority (HFEA), an independent entity responsible for managing the quality of procedures and treatments involving ART. Anchored in the Human Fertilisation and Embryology Act, the HFEA was established to regulate the full gamut of fertility treatment, gamete donation, and embryo research. Complementing the HFEA are the National Institute for Health and Care Excellence (NICE) and the Medicines and Healthcare Products Regulatory Agency (MHRA), responsible for clinical guidelines and the safety of medicines and medical devices, respectively, to form an integrated quality management system. The HFEA specifies statutory provisions, licensing conditions, and mandatory requirements through its Code of Practice, and enhances transparency and accountability by collecting and publishing treatment, outcome, and safety data through its register. This UK model, which links legal and regulatory structures with practical guidance and a registry, offers a useful reference framework for developing Korea’s quality management system for ART.

Attachments

공공누리 공공저작물 자유 이용허락, 출처표시, 상업적 이용 금지, 변경금지
  • No

    Subject

    Author

    Summary

    View

  • 5

    The Trump Administration’s Budget Bill (OBBBA) and Medicaid

    Ko, Hansoo, Cheon, Heejoo